PTH news

Invesco Dorsey Wright Healthcare Momentum · Biotechnology · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Market Screener · 28 Oct 2026, 12:21 UTC
United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension
3.4% of PTH
RTTNews · 28 Oct 2026, 11:38 UTC
United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy
3.4% of PTH
Investing.com · 28 Oct 2026, 15:33 UTC
Tenet Healthcare earnings loom as investors eye 2027 outlook By Investing.com
3.0% of PTH
Investing.com · 28 Oct 2026, 11:12 UTC
United Therapeutics gets FDA nod for PAH combination therapy trial By Investing.com
3.4% of PTH
Where to buy PTH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
wallstreet:online · 28 Oct 2026, 11:05 UTC
United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension
3.4% of PTH
The Manila times · 27 Oct 2026, 20:21 UTC
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
5.1% of PTH
Where to buy PTH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 14:16 UTC
HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track (NYSE:HCA) | Seeking Alpha
2.8% of PTH
Benzinga · 28 Oct 2026, 13:24 UTC
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results - HCA Healthcare
2.8% of PTH
Investing.com · 28 Oct 2026, 10:00 UTC
BofA raises HCA Healthcare stock price target on solid execution By Investing.com
2.8% of PTH
The Wall Street Journal · 28 Oct 2026, 20:17 UTC
Here's Why Moderna's CEO Isn't Fazed by Its Cancer-Vaccine Selloff
1.9% of PTH
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
1.9% of PTH
Seeking Alpha · 28 Oct 2026, 16:22 UTC
Moderna: ESMO Answered The Science, Q3 Has To Answer The Money (NASDAQ:MRNA) | Seeking Alpha
1.9% of PTH
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
1.9% of PTH
Investing.com · 28 Oct 2026, 14:13 UTC
Why is Moderna stock rebounding today? By Investing.com
1.9% of PTH
Seeking Alpha · 28 Oct 2026, 12:10 UTC
Fidelity Growth Company Fund Q3 2026 Commentary (FDGRX) | Seeking Alpha
1.9% of PTH
Investing.com · 28 Oct 2026, 15:42 UTC
Incyte earnings up next: Analysts eye loss amid pipeline gains By Investing.com
1.7% of PTH
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
1.6% of PTH
Market Screener · 28 Oct 2026, 14:41 UTC
Adagene Inc. Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte?S Inca33890 in Patients with Microsatellite Stable Colorectal Cancer
1.7% of PTH
Seeking Alpha · 27 Oct 2026, 20:43 UTC
HCA signals 2027 volume growth of 2%-3% while expecting $550M-$650M less in Medicaid supplemental net benefits (NYSE:HCA) | Seeking Alpha
2.8% of PTH
Seeking Alpha · 27 Oct 2026, 20:39 UTC
HCA Healthcare, Inc. (HCA) Q3 2026 Earnings Call Transcript | Seeking Alpha
2.8% of PTH

PTH news

Where to buy PTH

Where to buy PTH